An Observational Study of Adjuvant Treatment With Capecitabine (Xeloda) in Combination With Oxaliplatin in Participants With Stage III Colon Cancer
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Capecitabine
Related studies linked through entity extraction aliases.
Eribulin in Combination With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive Early Stage Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Epirubicin and Paclitaxel, Alone or Together With Capecitabine as First Line Treatment in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Study of Ruxolitinib in Pancreatic Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
An Observational Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) And Oxaliplatin in Patients With Colorectal Cancer
- Status
- COMPLETED
- Phase
- N/A
Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy for Resectable Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Bevacizumab + mFOLFOX6 Versus Bevacizumab + FOLFIRI With Biomarker Stratification in Participants With Previously Untreated Metastatic Colorectal Cancer (mCRC)
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and Previously Untreated Gastric Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Radiotherapy With Chemotherapy as Neoadjuvant Therapy of Resectable and Borderline Resectable Pancreas Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
GDC-0980 in Combination With a Fluoropyrimidine, Oxaliplatin, and Bevacizumab in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Open Label Dose-Finding Study of TRC105 Plus Capecitabine for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Confirmation Study of Eribulin in Combination With Capecitabine
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal Adenocarcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Study of BKM120 or BYL719 and Capecitabine in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the Pancreas
- Status
- COMPLETED
- Phase
- PHASE1
Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable Cancer
- Status
- COMPLETED
- Phase
- NA
Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- NA